FUJIFILM Diosynth Biotechnologies
The Drug Substance Tech Transfer Lead at Fujifilm Biotechnologies Denmark drives the end-to-end introduction of new programs into large-scale manufacturing operations. This role involves leading tech transfer activities, managing integrated project plans, and ensuring compliance with GMP requirements for clinical, PPQ, and commercial processes. The position requires close collaboration with internal stakeholders and customers to deliver successful product introductions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for FUJIFILM Diosynth Biotechnologies.
FUJIFILM Diosynth Biotechnologies didn’t post a salary, so this is our estimate from similar listings.
Scientist I, DevOps Drug Substance / Scientist II, DevOps Drug Substance
Digital Biology
Scientist I, DevOps Drug Substance / Scientist II, DevOps Drug Substance
Digital Biology
Scientist I/II, DevOps Drug Substance
Digital Biology
Engineer I, MS&T
Catalent
Associate Director, Upstream Biologics Drug Substance
Disc Medicine
Process Development Senior Scientist - Pivotal Biologics Drug Substance Technology
Amgen